nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluticasone Propionate—CYP3A4—Temozolomide—malignant glioma	0.0652	1	CbGbCtD
Fluticasone Propionate—Hyperadrenocorticism—Temozolomide—malignant glioma	0.0473	0.111	CcSEcCtD
Fluticasone Propionate—Cushing's syndrome—Carmustine—malignant glioma	0.0333	0.0785	CcSEcCtD
Fluticasone Propionate—Oral candidiasis—Carmustine—malignant glioma	0.0119	0.0281	CcSEcCtD
Fluticasone Propionate—Oral candidiasis—Temozolomide—malignant glioma	0.0115	0.0271	CcSEcCtD
Fluticasone Propionate—Influenza-like symptoms—Temozolomide—malignant glioma	0.0102	0.0241	CcSEcCtD
Fluticasone Propionate—Endocrine disorder—Temozolomide—malignant glioma	0.00882	0.0208	CcSEcCtD
Fluticasone Propionate—Viral infection—Temozolomide—malignant glioma	0.0081	0.0191	CcSEcCtD
Fluticasone Propionate—Herpes simplex—Temozolomide—malignant glioma	0.00794	0.0187	CcSEcCtD
Fluticasone Propionate—Candida infection—Carmustine—malignant glioma	0.00723	0.017	CcSEcCtD
Fluticasone Propionate—Influenza like illness—Temozolomide—malignant glioma	0.0071	0.0167	CcSEcCtD
Fluticasone Propionate—Candida infection—Temozolomide—malignant glioma	0.00698	0.0164	CcSEcCtD
Fluticasone Propionate—PGR—blood vessel—malignant glioma	0.00655	0.0943	CbGeAlD
Fluticasone Propionate—Diabetes mellitus—Carmustine—malignant glioma	0.00632	0.0149	CcSEcCtD
Fluticasone Propionate—Nasal congestion—Temozolomide—malignant glioma	0.00583	0.0137	CcSEcCtD
Fluticasone Propionate—Face oedema—Carmustine—malignant glioma	0.0053	0.0125	CcSEcCtD
Fluticasone Propionate—Face oedema—Temozolomide—malignant glioma	0.00513	0.0121	CcSEcCtD
Fluticasone Propionate—Abdominal distension—Temozolomide—malignant glioma	0.00462	0.0109	CcSEcCtD
Fluticasone Propionate—Bronchitis—Temozolomide—malignant glioma	0.00441	0.0104	CcSEcCtD
Fluticasone Propionate—Hyperglycaemia—Carmustine—malignant glioma	0.00428	0.0101	CcSEcCtD
Fluticasone Propionate—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00426	0.01	CcSEcCtD
Fluticasone Propionate—Pneumonia—Carmustine—malignant glioma	0.00426	0.01	CcSEcCtD
Fluticasone Propionate—Hyperglycaemia—Temozolomide—malignant glioma	0.00414	0.00975	CcSEcCtD
Fluticasone Propionate—Pneumonia—Temozolomide—malignant glioma	0.00412	0.00969	CcSEcCtD
Fluticasone Propionate—Infestation NOS—Temozolomide—malignant glioma	0.00409	0.00964	CcSEcCtD
Fluticasone Propionate—Infestation—Temozolomide—malignant glioma	0.00409	0.00964	CcSEcCtD
Fluticasone Propionate—NR3C2—brainstem—malignant glioma	0.00385	0.0554	CbGeAlD
Fluticasone Propionate—Sinusitis—Temozolomide—malignant glioma	0.00384	0.00904	CcSEcCtD
Fluticasone Propionate—Hypoaesthesia—Carmustine—malignant glioma	0.00378	0.00891	CcSEcCtD
Fluticasone Propionate—Connective tissue disorder—Carmustine—malignant glioma	0.00373	0.0088	CcSEcCtD
Fluticasone Propionate—NR3C2—retina—malignant glioma	0.00372	0.0535	CbGeAlD
Fluticasone Propionate—Hypoaesthesia—Temozolomide—malignant glioma	0.00365	0.00861	CcSEcCtD
Fluticasone Propionate—Pharyngitis—Temozolomide—malignant glioma	0.00365	0.00859	CcSEcCtD
Fluticasone Propionate—Connective tissue disorder—Temozolomide—malignant glioma	0.00361	0.0085	CcSEcCtD
Fluticasone Propionate—Eye disorder—Carmustine—malignant glioma	0.00355	0.00837	CcSEcCtD
Fluticasone Propionate—Eye disorder—Temozolomide—malignant glioma	0.00343	0.00809	CcSEcCtD
Fluticasone Propionate—NR3C2—telencephalon—malignant glioma	0.00342	0.0492	CbGeAlD
Fluticasone Propionate—Cardiac disorder—Temozolomide—malignant glioma	0.00341	0.00803	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Carmustine—malignant glioma	0.0034	0.008	CcSEcCtD
Fluticasone Propionate—Mental disorder—Carmustine—malignant glioma	0.00333	0.00784	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Temozolomide—malignant glioma	0.00332	0.00781	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Temozolomide—malignant glioma	0.00331	0.0078	CcSEcCtD
Fluticasone Propionate—Malnutrition—Carmustine—malignant glioma	0.00331	0.00779	CcSEcCtD
Fluticasone Propionate—Erythema—Carmustine—malignant glioma	0.00331	0.00779	CcSEcCtD
Fluticasone Propionate—PLA2G4A—medulla oblongata—malignant glioma	0.0033	0.0475	CbGeAlD
Fluticasone Propionate—Mental disorder—Temozolomide—malignant glioma	0.00322	0.00758	CcSEcCtD
Fluticasone Propionate—Malnutrition—Temozolomide—malignant glioma	0.0032	0.00753	CcSEcCtD
Fluticasone Propionate—Erythema—Temozolomide—malignant glioma	0.0032	0.00753	CcSEcCtD
Fluticasone Propionate—Vision blurred—Carmustine—malignant glioma	0.00312	0.00734	CcSEcCtD
Fluticasone Propionate—Tremor—Carmustine—malignant glioma	0.0031	0.0073	CcSEcCtD
Fluticasone Propionate—Agitation—Carmustine—malignant glioma	0.00304	0.00716	CcSEcCtD
Fluticasone Propionate—PLA2G4A—midbrain—malignant glioma	0.00302	0.0434	CbGeAlD
Fluticasone Propionate—Vision blurred—Temozolomide—malignant glioma	0.00301	0.0071	CcSEcCtD
Fluticasone Propionate—Tremor—Temozolomide—malignant glioma	0.003	0.00706	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Temozolomide—malignant glioma	0.00297	0.00699	CcSEcCtD
Fluticasone Propionate—PLA2G4A—spinal cord—malignant glioma	0.00295	0.0424	CbGeAlD
Fluticasone Propionate—Agitation—Temozolomide—malignant glioma	0.00294	0.00692	CcSEcCtD
Fluticasone Propionate—Angioedema—Temozolomide—malignant glioma	0.00292	0.00688	CcSEcCtD
Fluticasone Propionate—Malaise—Temozolomide—malignant glioma	0.00288	0.00679	CcSEcCtD
Fluticasone Propionate—Hypertension—Carmustine—malignant glioma	0.00286	0.00673	CcSEcCtD
Fluticasone Propionate—Palpitations—Temozolomide—malignant glioma	0.00283	0.00666	CcSEcCtD
Fluticasone Propionate—Chest pain—Carmustine—malignant glioma	0.00282	0.00663	CcSEcCtD
Fluticasone Propionate—Anxiety—Carmustine—malignant glioma	0.00281	0.00661	CcSEcCtD
Fluticasone Propionate—Cough—Temozolomide—malignant glioma	0.00279	0.00657	CcSEcCtD
Fluticasone Propionate—Hypertension—Temozolomide—malignant glioma	0.00276	0.0065	CcSEcCtD
Fluticasone Propionate—Arthralgia—Temozolomide—malignant glioma	0.00272	0.00641	CcSEcCtD
Fluticasone Propionate—Anxiety—Temozolomide—malignant glioma	0.00271	0.00639	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.0027	0.00637	CcSEcCtD
Fluticasone Propionate—Oedema—Carmustine—malignant glioma	0.0027	0.00636	CcSEcCtD
Fluticasone Propionate—Discomfort—Temozolomide—malignant glioma	0.00269	0.00633	CcSEcCtD
Fluticasone Propionate—NR3C2—medulla oblongata—malignant glioma	0.00269	0.0386	CbGeAlD
Fluticasone Propionate—Infection—Carmustine—malignant glioma	0.00268	0.00632	CcSEcCtD
Fluticasone Propionate—Dry mouth—Temozolomide—malignant glioma	0.00266	0.00627	CcSEcCtD
Fluticasone Propionate—Tachycardia—Carmustine—malignant glioma	0.00264	0.00621	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Temozolomide—malignant glioma	0.00261	0.00615	CcSEcCtD
Fluticasone Propionate—Oedema—Temozolomide—malignant glioma	0.00261	0.00615	CcSEcCtD
Fluticasone Propionate—Infection—Temozolomide—malignant glioma	0.00259	0.00611	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Temozolomide—malignant glioma	0.00256	0.00603	CcSEcCtD
Fluticasone Propionate—Skin disorder—Temozolomide—malignant glioma	0.00253	0.00597	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00246	0.00579	CcSEcCtD
Fluticasone Propionate—NR3C2—midbrain—malignant glioma	0.00246	0.0353	CbGeAlD
Fluticasone Propionate—Dyspnoea—Carmustine—malignant glioma	0.00241	0.00567	CcSEcCtD
Fluticasone Propionate—NR3C2—spinal cord—malignant glioma	0.0024	0.0345	CbGeAlD
Fluticasone Propionate—PLA2G4A—central nervous system—malignant glioma	0.00239	0.0344	CbGeAlD
Fluticasone Propionate—SERPINA6—central nervous system—malignant glioma	0.00238	0.0342	CbGeAlD
Fluticasone Propionate—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00238	0.0056	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Temozolomide—malignant glioma	0.00233	0.00548	CcSEcCtD
Fluticasone Propionate—SERPINA6—cerebellum—malignant glioma	0.00233	0.0335	CbGeAlD
Fluticasone Propionate—Pain—Carmustine—malignant glioma	0.00231	0.00544	CcSEcCtD
Fluticasone Propionate—NR3C1—embryo—malignant glioma	0.00225	0.0324	CbGeAlD
Fluticasone Propionate—Pain—Temozolomide—malignant glioma	0.00223	0.00526	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Carmustine—malignant glioma	0.00223	0.00524	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Carmustine—malignant glioma	0.00221	0.0052	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Temozolomide—malignant glioma	0.00215	0.00507	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Carmustine—malignant glioma	0.00213	0.00503	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Carmustine—malignant glioma	0.00213	0.00503	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Temozolomide—malignant glioma	0.00213	0.00503	CcSEcCtD
Fluticasone Propionate—Urticaria—Temozolomide—malignant glioma	0.00207	0.00488	CcSEcCtD
Fluticasone Propionate—NR3C1—brainstem—malignant glioma	0.00207	0.0297	CbGeAlD
Fluticasone Propionate—Abdominal pain—Temozolomide—malignant glioma	0.00206	0.00486	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Temozolomide—malignant glioma	0.00206	0.00486	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Carmustine—malignant glioma	0.00199	0.00469	CcSEcCtD
Fluticasone Propionate—NR3C2—central nervous system—malignant glioma	0.00194	0.028	CbGeAlD
Fluticasone Propionate—Hypersensitivity—Temozolomide—malignant glioma	0.00192	0.00453	CcSEcCtD
Fluticasone Propionate—NR3C2—cerebellum—malignant glioma	0.0019	0.0273	CbGeAlD
Fluticasone Propionate—PLA2G4A—brain—malignant glioma	0.0019	0.0273	CbGeAlD
Fluticasone Propionate—SERPINA6—brain—malignant glioma	0.00189	0.0272	CbGeAlD
Fluticasone Propionate—Diarrhoea—Carmustine—malignant glioma	0.00185	0.00435	CcSEcCtD
Fluticasone Propionate—Pruritus—Temozolomide—malignant glioma	0.00185	0.00435	CcSEcCtD
Fluticasone Propionate—NR3C1—telencephalon—malignant glioma	0.00183	0.0264	CbGeAlD
Fluticasone Propionate—PGR—central nervous system—malignant glioma	0.00181	0.026	CbGeAlD
Fluticasone Propionate—Dizziness—Carmustine—malignant glioma	0.00179	0.00421	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Temozolomide—malignant glioma	0.00179	0.00421	CcSEcCtD
Fluticasone Propionate—PGR—cerebellum—malignant glioma	0.00177	0.0254	CbGeAlD
Fluticasone Propionate—Dizziness—Temozolomide—malignant glioma	0.00173	0.00406	CcSEcCtD
Fluticasone Propionate—Vomiting—Carmustine—malignant glioma	0.00172	0.00404	CcSEcCtD
Fluticasone Propionate—Rash—Carmustine—malignant glioma	0.0017	0.00401	CcSEcCtD
Fluticasone Propionate—Dermatitis—Carmustine—malignant glioma	0.0017	0.00401	CcSEcCtD
Fluticasone Propionate—Headache—Carmustine—malignant glioma	0.00169	0.00398	CcSEcCtD
Fluticasone Propionate—Vomiting—Temozolomide—malignant glioma	0.00166	0.00391	CcSEcCtD
Fluticasone Propionate—Rash—Temozolomide—malignant glioma	0.00165	0.00388	CcSEcCtD
Fluticasone Propionate—Dermatitis—Temozolomide—malignant glioma	0.00164	0.00387	CcSEcCtD
Fluticasone Propionate—Headache—Temozolomide—malignant glioma	0.00163	0.00385	CcSEcCtD
Fluticasone Propionate—Nausea—Carmustine—malignant glioma	0.0016	0.00378	CcSEcCtD
Fluticasone Propionate—Nausea—Temozolomide—malignant glioma	0.00155	0.00365	CcSEcCtD
Fluticasone Propionate—NR3C2—brain—malignant glioma	0.00154	0.0222	CbGeAlD
Fluticasone Propionate—NR3C1—medulla oblongata—malignant glioma	0.00144	0.0207	CbGeAlD
Fluticasone Propionate—PGR—brain—malignant glioma	0.00143	0.0206	CbGeAlD
Fluticasone Propionate—NR3C1—midbrain—malignant glioma	0.00132	0.0189	CbGeAlD
Fluticasone Propionate—NR3C1—spinal cord—malignant glioma	0.00128	0.0185	CbGeAlD
Fluticasone Propionate—Triamcinolone—BCHE—malignant glioma	0.00126	0.378	CrCbGaD
Fluticasone Propionate—NR3C1—central nervous system—malignant glioma	0.00104	0.015	CbGeAlD
Fluticasone Propionate—NR3C1—cerebellum—malignant glioma	0.00102	0.0147	CbGeAlD
Fluticasone Propionate—NR3C1—brain—malignant glioma	0.000828	0.0119	CbGeAlD
Fluticasone Propionate—CYP3A4—central nervous system—malignant glioma	0.000788	0.0113	CbGeAlD
Fluticasone Propionate—Dexamethasone—CYP2B6—malignant glioma	0.000737	0.221	CrCbGaD
Fluticasone Propionate—Triamcinolone—PTGS2—malignant glioma	0.000582	0.174	CrCbGaD
Fluticasone Propionate—Betamethasone—PTGS2—malignant glioma	0.000477	0.143	CrCbGaD
Fluticasone Propionate—Dexamethasone—PTGS2—malignant glioma	0.000277	0.0831	CrCbGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000221	0.000505	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ASMT—malignant glioma	0.000217	0.000497	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—HIST1H3B—malignant glioma	0.000216	0.000495	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—NCOR1—malignant glioma	0.000216	0.000494	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—GSTT1—malignant glioma	0.000216	0.000493	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CYP2B6—malignant glioma	0.000214	0.00049	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	0.000209	0.000478	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—RTEL1—malignant glioma	0.000207	0.000473	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—MMP3—malignant glioma	0.000207	0.000472	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—H3F3A—malignant glioma	0.000205	0.000468	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Biological oxidations—GSTP1—malignant glioma	0.000205	0.000468	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—BCAN—malignant glioma	0.000204	0.000467	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CXCR3—malignant glioma	0.000203	0.000463	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PTGS1—malignant glioma	0.000202	0.000462	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	0.000202	0.000461	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000201	0.00046	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—JAG2—malignant glioma	0.000198	0.000452	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—RAF1—malignant glioma	0.000197	0.000451	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—YWHAE—malignant glioma	0.000197	0.000451	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—NTRK2—malignant glioma	0.000197	0.000451	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—NOTCH1—malignant glioma	0.000197	0.00045	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—FLT1—malignant glioma	0.000196	0.000449	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—IDH1—malignant glioma	0.000196	0.000448	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—DUSP6—malignant glioma	0.000195	0.000447	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—JAG1—malignant glioma	0.000193	0.000441	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—PIK3CB—malignant glioma	0.000193	0.00044	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—NOTCH3—malignant glioma	0.000192	0.000439	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—SPHK1—malignant glioma	0.00019	0.000433	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—FBXW7—malignant glioma	0.000189	0.000432	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—BCHE—malignant glioma	0.000188	0.000429	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—AKT1—malignant glioma	0.000186	0.000425	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—PPARG—malignant glioma	0.000186	0.000425	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CYP2C18—malignant glioma	0.000186	0.000425	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—SLC5A5—malignant glioma	0.000185	0.000424	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—BDKRB2—malignant glioma	0.000185	0.000424	CbGpPWpGaD
Fluticasone Propionate—PGR—Generic Transcription Pathway—MYC—malignant glioma	0.000183	0.000419	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—H3F3A—malignant glioma	0.000182	0.000416	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—IL2—malignant glioma	0.000177	0.000404	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000175	0.000401	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000174	0.000397	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—NOTCH2—malignant glioma	0.000172	0.000394	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—NOTCH3—malignant glioma	0.000171	0.000391	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—KNG1—malignant glioma	0.000169	0.000386	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—H3F3A—malignant glioma	0.000167	0.000382	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CXCR3—malignant glioma	0.000166	0.000379	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—IDH2—malignant glioma	0.000165	0.000376	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—NOTCH1—malignant glioma	0.000164	0.000375	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—YWHAE—malignant glioma	0.000161	0.000368	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NTRK2—malignant glioma	0.000161	0.000368	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—NTRK1—malignant glioma	0.000161	0.000367	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—FLT1—malignant glioma	0.00016	0.000367	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—DUSP6—malignant glioma	0.00016	0.000365	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—JAG1—malignant glioma	0.000158	0.00036	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NOTCH3—malignant glioma	0.000157	0.000359	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—PPARG—malignant glioma	0.000155	0.000354	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CYP2B6—malignant glioma	0.000155	0.000354	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—FBXW7—malignant glioma	0.000154	0.000353	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—NOTCH2—malignant glioma	0.000153	0.00035	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000152	0.000346	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—BDKRB2—malignant glioma	0.000151	0.000346	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—F2—malignant glioma	0.000151	0.000345	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—VEGFA—malignant glioma	0.00015	0.000344	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—GSTT1—malignant glioma	0.00015	0.000343	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MMP3—malignant glioma	0.000149	0.000342	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—GSTP1—malignant glioma	0.000149	0.000341	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CDKN2B—malignant glioma	0.000148	0.000339	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—CAT—malignant glioma	0.000145	0.000332	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—MYC—malignant glioma	0.000145	0.000331	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—PIK3CG—malignant glioma	0.000144	0.00033	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PTK2—malignant glioma	0.000144	0.000329	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—PTPN11—malignant glioma	0.000142	0.000324	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—IDH1—malignant glioma	0.000142	0.000324	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—HES1—malignant glioma	0.000141	0.000323	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NOTCH2—malignant glioma	0.000141	0.000322	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PTGS1—malignant glioma	0.000141	0.000322	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—NCOR1—malignant glioma	0.000141	0.000321	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—KNG1—malignant glioma	0.000138	0.000315	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—NCOR1—malignant glioma	0.000137	0.000314	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—SPHK1—malignant glioma	0.000137	0.000313	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PDGFRA—malignant glioma	0.000135	0.000308	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CYP2C18—malignant glioma	0.000134	0.000307	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—AKT2—malignant glioma	0.000132	0.000302	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—CDKN2B—malignant glioma	0.000132	0.000301	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NTRK1—malignant glioma	0.000131	0.0003	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—BCHE—malignant glioma	0.000131	0.000299	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—SPP1—malignant glioma	0.000131	0.000299	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—SLC5A5—malignant glioma	0.000129	0.000295	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—KRAS—malignant glioma	0.000128	0.000292	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—PIK3CD—malignant glioma	0.000127	0.00029	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—NCOR1—malignant glioma	0.000125	0.000286	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TERT—malignant glioma	0.000124	0.000283	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MMP3—malignant glioma	0.000122	0.000279	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CDKN2B—malignant glioma	0.000121	0.000277	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PDGFB—malignant glioma	0.000121	0.000276	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—FGFR1—malignant glioma	0.00012	0.000275	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—COX8A—malignant glioma	0.000119	0.000272	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—HIF1A—malignant glioma	0.000118	0.000271	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PTK2—malignant glioma	0.000118	0.000269	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—PIK3CA—malignant glioma	0.000117	0.000268	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—HES1—malignant glioma	0.000115	0.000264	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NCOR1—malignant glioma	0.000115	0.000262	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CAV1—malignant glioma	0.000115	0.000262	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—TP53—malignant glioma	0.000114	0.00026	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—KDR—malignant glioma	0.000113	0.000259	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—RAF1—malignant glioma	0.000113	0.000259	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—CAV1—malignant glioma	0.000112	0.000256	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—PIK3CB—malignant glioma	0.000111	0.000253	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PDGFRA—malignant glioma	0.00011	0.000251	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—F2—malignant glioma	0.000109	0.000249	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—FN1—malignant glioma	0.000109	0.000249	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GSTT1—malignant glioma	0.000109	0.000248	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—BAD—malignant glioma	0.000108	0.000246	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000107	0.000244	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—SPP1—malignant glioma	0.000107	0.000244	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—NOTCH1—malignant glioma	0.000107	0.000244	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—CXCL8—malignant glioma	0.000106	0.000243	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—MYC—malignant glioma	0.000106	0.000242	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CD80—malignant glioma	0.000105	0.000239	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—APC—malignant glioma	0.000104	0.000239	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PIK3CG—malignant glioma	0.000104	0.000239	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—GSTP1—malignant glioma	0.000104	0.000238	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—EGF—malignant glioma	0.000103	0.000236	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PTPN11—malignant glioma	0.000102	0.000234	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PIK3CG—malignant glioma	0.000102	0.000233	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PTGS1—malignant glioma	0.000102	0.000233	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—IL2—malignant glioma	0.000102	0.000232	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CAT—malignant glioma	0.000101	0.000232	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TERT—malignant glioma	0.000101	0.000231	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ASMT—malignant glioma	0.000101	0.000231	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—AKT1—malignant glioma	0.000101	0.00023	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PDGFB—malignant glioma	9.87e-05	0.000226	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PPARG—malignant glioma	9.84e-05	0.000225	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—FGFR1—malignant glioma	9.82e-05	0.000225	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—BRAF—malignant glioma	9.81e-05	0.000224	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—HIF1A—malignant glioma	9.67e-05	0.000221	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—AKT1—malignant glioma	9.59e-05	0.000219	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—NCOR1—malignant glioma	9.57e-05	0.000219	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—AKT2—malignant glioma	9.55e-05	0.000218	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—BCAN—malignant glioma	9.5e-05	0.000217	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—NOTCH1—malignant glioma	9.48e-05	0.000217	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—BCHE—malignant glioma	9.46e-05	0.000216	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CAV1—malignant glioma	9.36e-05	0.000214	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—SLC5A5—malignant glioma	9.34e-05	0.000214	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—KDR—malignant glioma	9.25e-05	0.000212	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PIK3CD—malignant glioma	9.17e-05	0.00021	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PIK3CD—malignant glioma	8.96e-05	0.000205	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—PPARG—malignant glioma	8.95e-05	0.000205	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—F2—malignant glioma	8.91e-05	0.000204	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—FN1—malignant glioma	8.91e-05	0.000204	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—MYC—malignant glioma	8.83e-05	0.000202	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—BAD—malignant glioma	8.8e-05	0.000201	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—FGF2—malignant glioma	8.78e-05	0.000201	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NOTCH1—malignant glioma	8.72e-05	0.000199	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CD80—malignant glioma	8.54e-05	0.000195	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—APC—malignant glioma	8.52e-05	0.000195	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PIK3CG—malignant glioma	8.52e-05	0.000195	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—EGF—malignant glioma	8.42e-05	0.000193	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PTPN11—malignant glioma	8.37e-05	0.000191	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MDM2—malignant glioma	8.22e-05	0.000188	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—RAF1—malignant glioma	8.19e-05	0.000187	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—ERBB2—malignant glioma	8.1e-05	0.000185	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—BRAF—malignant glioma	8.01e-05	0.000183	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PIK3CB—malignant glioma	7.99e-05	0.000183	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PIK3CB—malignant glioma	7.81e-05	0.000179	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CAV1—malignant glioma	7.8e-05	0.000178	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—AKT2—malignant glioma	7.8e-05	0.000178	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—EGFR—malignant glioma	7.76e-05	0.000178	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PTGS2—malignant glioma	7.74e-05	0.000177	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CXCL8—malignant glioma	7.68e-05	0.000176	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—IDH2—malignant glioma	7.66e-05	0.000175	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GSTP1—malignant glioma	7.52e-05	0.000172	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PIK3CD—malignant glioma	7.49e-05	0.000171	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CASP3—malignant glioma	7.35e-05	0.000168	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IL2—malignant glioma	7.34e-05	0.000168	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—KRAS—malignant glioma	7.34e-05	0.000168	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CAT—malignant glioma	7.32e-05	0.000167	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYP2B6—malignant glioma	7.2e-05	0.000165	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—FGF2—malignant glioma	7.17e-05	0.000164	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PIK3CG—malignant glioma	7.1e-05	0.000162	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MMP9—malignant glioma	6.95e-05	0.000159	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—NCOR1—malignant glioma	6.91e-05	0.000158	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PTEN—malignant glioma	6.91e-05	0.000158	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PPARG—malignant glioma	6.86e-05	0.000157	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PTEN—malignant glioma	6.75e-05	0.000154	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—PIK3CA—malignant glioma	6.74e-05	0.000154	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MDM2—malignant glioma	6.71e-05	0.000153	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—RAF1—malignant glioma	6.69e-05	0.000153	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—ERBB2—malignant glioma	6.62e-05	0.000151	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—IDH1—malignant glioma	6.58e-05	0.00015	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PIK3CB—malignant glioma	6.53e-05	0.000149	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—SPHK1—malignant glioma	6.37e-05	0.000146	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CXCL8—malignant glioma	6.28e-05	0.000143	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PIK3CD—malignant glioma	6.24e-05	0.000143	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYP2C18—malignant glioma	6.24e-05	0.000143	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—VEGFA—malignant glioma	6.24e-05	0.000143	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—STAT3—malignant glioma	6.18e-05	0.000141	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—AKT1—malignant glioma	6.12e-05	0.00014	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CASP3—malignant glioma	6.01e-05	0.000137	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IL2—malignant glioma	6e-05	0.000137	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MYC—malignant glioma	5.74e-05	0.000131	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MMP9—malignant glioma	5.68e-05	0.00013	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PTEN—malignant glioma	5.64e-05	0.000129	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CAV1—malignant glioma	5.64e-05	0.000129	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—EGFR—malignant glioma	5.61e-05	0.000128	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—AKT1—malignant glioma	5.51e-05	0.000126	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PIK3CB—malignant glioma	5.44e-05	0.000124	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PTGS2—malignant glioma	5.39e-05	0.000123	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—KRAS—malignant glioma	5.3e-05	0.000121	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PIK3CG—malignant glioma	5.13e-05	0.000117	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—MYC—malignant glioma	5.1e-05	0.000117	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—VEGFA—malignant glioma	5.1e-05	0.000117	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GSTT1—malignant glioma	5.05e-05	0.000115	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—STAT3—malignant glioma	5.05e-05	0.000115	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PPARG—malignant glioma	4.96e-05	0.000113	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PIK3CA—malignant glioma	4.87e-05	0.000111	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PIK3CA—malignant glioma	4.76e-05	0.000109	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PTGS1—malignant glioma	4.73e-05	0.000108	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TP53—malignant glioma	4.71e-05	0.000108	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PTEN—malignant glioma	4.7e-05	0.000108	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MYC—malignant glioma	4.69e-05	0.000107	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—EGFR—malignant glioma	4.59e-05	0.000105	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PIK3CD—malignant glioma	4.51e-05	0.000103	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—BCHE—malignant glioma	4.4e-05	0.000101	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—SLC5A5—malignant glioma	4.34e-05	9.93e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—KRAS—malignant glioma	4.33e-05	9.91e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—AKT1—malignant glioma	3.98e-05	9.1e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PIK3CA—malignant glioma	3.98e-05	9.1e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PIK3CB—malignant glioma	3.93e-05	8.99e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PTGS2—malignant glioma	3.9e-05	8.91e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—AKT1—malignant glioma	3.89e-05	8.89e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TP53—malignant glioma	3.85e-05	8.8e-05	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—AKT1—malignant glioma	3.54e-05	8.09e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GSTP1—malignant glioma	3.5e-05	8e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CAT—malignant glioma	3.4e-05	7.78e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PTEN—malignant glioma	3.4e-05	7.77e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PIK3CA—malignant glioma	3.32e-05	7.59e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—AKT1—malignant glioma	3.25e-05	7.43e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—NCOR1—malignant glioma	3.21e-05	7.35e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—AKT1—malignant glioma	2.71e-05	6.2e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CAV1—malignant glioma	2.62e-05	5.99e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PIK3CA—malignant glioma	2.4e-05	5.48e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PIK3CG—malignant glioma	2.39e-05	5.46e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PPARG—malignant glioma	2.3e-05	5.27e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PIK3CD—malignant glioma	2.1e-05	4.8e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—AKT1—malignant glioma	1.96e-05	4.48e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.83e-05	4.18e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PTGS2—malignant glioma	1.81e-05	4.14e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PTEN—malignant glioma	1.58e-05	3.61e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.12e-05	2.55e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—AKT1—malignant glioma	9.11e-06	2.08e-05	CbGpPWpGaD
